All early-stage founders developing tools and services for biotechnology, biomedicine, cell biology, molecular biology, genetics and biochemistry are encouraged to apply. Acceptance into the BioTools Innovator accelerator is based on the stage of the startup, with preference for companies that have not yet raised a Series B or established a significant strategic partnership.